Liddle C - Search Results

1

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells.

Zhou G, Da Won Bae S, Nguyen R, Huo X, Han S, Zhang Z, Hebbard L, Duan W, Eslam M, Liddle C, Yuen L, Lam V, Qiao L, George J. Zhou G, et al. Among authors: liddle c. Cancer Lett. 2021 Mar 31;501:124-132. doi: 10.1016/j.canlet.2020.12.022. Epub 2020 Dec 19. Cancer Lett. 2021. PMID: 33352247

2

Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis.

George J, Liddle C, Murray M, Byth K, Farrell GC. George J, et al. Among authors: liddle c. Biochem Pharmacol. 1995 Mar 30;49(7):873-81. doi: 10.1016/0006-2952(94)00515-n. Biochem Pharmacol. 1995. PMID: 7741759

3

Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes.

Tapner M, Liddle C, Goodwin B, George J, Farrell GC. Tapner M, et al. Among authors: liddle c. Hepatology. 1996 Aug;24(2):367-73. doi: 10.1002/hep.510240213. Hepatology. 1996. PMID: 8690406

4

Time-dependent expression of cytochrome P450 genes in primary cultures of well-differentiated human hepatocytes.

George J, Goodwin B, Liddle C, Tapner M, Farrell GC. George J, et al. Among authors: liddle c. J Lab Clin Med. 1997 Jun;129(6):638-48. doi: 10.1016/s0022-2143(97)90199-2. J Lab Clin Med. 1997. PMID: 9178731

5

Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes.

Liddle C, Goodwin BJ, George J, Tapner M, Farrell GC. Liddle C, et al. J Clin Endocrinol Metab. 1998 Jul;83(7):2411-6. doi: 10.1210/jcem.83.7.4877. J Clin Endocrinol Metab. 1998. PMID: 9661620

6

Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance.

Hui JM, George J, Liddle C, Lin R, Samarasinghe D, Crewe E, Farrell GC. Hui JM, et al. Among authors: liddle c. Am J Gastroenterol. 2002 Apr;97(4):1003-9. doi: 10.1111/j.1572-0241.2002.05621.x. Am J Gastroenterol. 2002. PMID: 12003380

7

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.

Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J. Chitturi S, et al. Among authors: liddle c. Hepatology. 2002 Jul;36(1):142-9. doi: 10.1053/jhep.2002.33892. Hepatology. 2002. PMID: 12085358

8

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J. Chitturi S, et al. Among authors: liddle c. Hepatology. 2002 Aug;36(2):403-9. doi: 10.1053/jhep.2002.34738. Hepatology. 2002. PMID: 12143049

9

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

Hui JM, Kench J, Farrell GC, Lin R, Samarasinghe D, Liddle C, Byth K, George J. Hui JM, et al. Among authors: liddle c. J Gastroenterol Hepatol. 2002 Aug;17(8):873-81. doi: 10.1046/j.1440-1746.2002.02813.x. J Gastroenterol Hepatol. 2002. PMID: 12164963

10

Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting.

Kumar D, Wallington-Beddoe C, George J, Lin R, Samarasinghe D, Liddle C, Farrell GC. Kumar D, et al. Among authors: liddle c. Med J Aust. 2003 Mar 17;178(6):267-71. doi: 10.5694/j.1326-5377.2003.tb05192.x. Med J Aust. 2003. PMID: 12633483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters